Skip to main content
Premium Trial:

Request an Annual Quote

FDA, CMS Seek to Speed Device Decisions

NEW YORK (GenomeWeb News) – The US Food and Drug Administration and the Centers for Medicare and Medicaid Services are weighing the use of a parallel review process for medical devices that would speed up the process of making coverage decisions, and they have started a pilot program to try out the idea.

In a notice published today FDA said that the Parallel Review plan is intended to reduce the time between FDA marketing approval and CMS national coverage determinations, which could improve care by bringing new medical products to more patients sooner, would increase efficiency in the government, and facilitate development of new devices.

To start the program, the agencies are soliciting nominations from sponsors of innovative device technologies to participate in a pilot program to test the concurrent review of FDA premarket review and CMS coverage determinations.

The agencies took comments from the public last year that suggested, among other things, that a parallel review program should be voluntary, should include an opt-out from national coverage determinations, should have clear standards for confidentiality and data sharing between the agencies, and should have clear guidelines on the procedure and timeline for the review process.

FDA and CMS said those comments informed the development of this medical device pilot program and the agencies intend to seek input and feedback from the candidate sponsors and requesters who are involved in the pilot.


For more on the pilot program see GenomeWeb Daily News sister publication Pharmacogenomics Reporter.

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.